| Original Article Online Published: 01 Jan 2026 | ||||||||||||
IJMDC. 2025; 9(12): 3185-3193 Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated systematic review and meta-analysis Ahlam Saad Almuabdi, Juwhra Sadiq Alturkostani, Marwah Alsulami, Shouq Aljohani, Latifah Alansari, Yousef Magbool, Morooj Mahnashi.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Almuabdi AS, Alturkostani JS, Alsulami M, Aljohani S, Alansari L, Magbool Y, Mahnashi M. Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated systematic review and meta-analysis. IJMDC. 2025; 9(12): 3185-3193. doi:10.24911/IJMDC.51-1764006113 Web Style Almuabdi AS, Alturkostani JS, Alsulami M, Aljohani S, Alansari L, Magbool Y, Mahnashi M. Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated systematic review and meta-analysis. https://www.ijmdc.com/?mno=299116 [Access: January 16, 2026]. doi:10.24911/IJMDC.51-1764006113 AMA (American Medical Association) Style Almuabdi AS, Alturkostani JS, Alsulami M, Aljohani S, Alansari L, Magbool Y, Mahnashi M. Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated
systematic review and meta-analysis. IJMDC. 2025; 9(12): 3185-3193. doi:10.24911/IJMDC.51-1764006113 Vancouver/ICMJE Style Almuabdi AS, Alturkostani JS, Alsulami M, Aljohani S, Alansari L, Magbool Y, Mahnashi M. Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated
systematic review and meta-analysis. IJMDC. (2025), [cited January 16, 2026]; 9(12): 3185-3193. doi:10.24911/IJMDC.51-1764006113 Harvard Style Almuabdi, A. S., Alturkostani, . J. S., Alsulami, . M., Aljohani, . S., Alansari, . L., Magbool, . Y. & Mahnashi, . M. (2025) Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated
systematic review and meta-analysis. IJMDC, 9 (12), 3185-3193. doi:10.24911/IJMDC.51-1764006113 Turabian Style Almuabdi, Ahlam Saad, Juwhra Sadiq Alturkostani, Marwah Alsulami, Shouq Aljohani, Latifah Alansari, Yousef Magbool, and Morooj Mahnashi. 2025. Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated
systematic review and meta-analysis. International Journal of Medicine in Developing Countries, 9 (12), 3185-3193. doi:10.24911/IJMDC.51-1764006113 Chicago Style Almuabdi, Ahlam Saad, Juwhra Sadiq Alturkostani, Marwah Alsulami, Shouq Aljohani, Latifah Alansari, Yousef Magbool, and Morooj Mahnashi. "Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated
systematic review and meta-analysis." International Journal of Medicine in Developing Countries 9 (2025), 3185-3193. doi:10.24911/IJMDC.51-1764006113 MLA (The Modern Language Association) Style Almuabdi, Ahlam Saad, Juwhra Sadiq Alturkostani, Marwah Alsulami, Shouq Aljohani, Latifah Alansari, Yousef Magbool, and Morooj Mahnashi. "Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated
systematic review and meta-analysis." International Journal of Medicine in Developing Countries 9.12 (2025), 3185-3193. Print. doi:10.24911/IJMDC.51-1764006113 APA (American Psychological Association) Style Almuabdi, A. S., Alturkostani, . J. S., Alsulami, . M., Aljohani, . S., Alansari, . L., Magbool, . Y. & Mahnashi, . M. (2025) Therapeutic impact and tolerability of intravenous immunoglobulin in pediatric autoimmune neuropsychiatric syndromes (PANS and PANDAS): an updated
systematic review and meta-analysis. International Journal of Medicine in Developing Countries, 9 (12), 3185-3193. doi:10.24911/IJMDC.51-1764006113 |